HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Straighten the cleaning solution Pour it into the cleaning position for cleaning Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes,ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
Saline Solution is intended for use in OTC ear,nose,and throat devices intended specifically to administer medicinal substances to treat ear,nose,and throat disorders.These instruments include the powder blower,dropper,ear wick,manual nebulizer pump,and nasal inhaler. If using with an OTC ear,nose,or throat device,the follow the directions provided with the device and only use as directed.
HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes, ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each mL contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 5.3 (4.5 to 7.0). Sodium Chloride, USP is chemically designated NaCl, a white crystalline compound freely soluble in water. The glass container is a Type I borosilicate glass and meets the requirements of the powdered glass test according to the USP standards. The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The pH ranges from 4.5 to 7.0. Composition, osmolarity, and ionic concentration are shown below: 0.9% Sodium Chloride Injection, USP contains 9 g/L Sodium Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (calc). It contains 154 mEq/L sodium and 154 mEq/L chloride. The FLEBOFLEX and FLEBOFLEX LUER plastic containers are fabricated from latex-free polyolefins or polypropylene plastic materials. The solution contact materials do not contain PVC, DEHP, or other plasticizers. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. The suitability of the container materials has been established through biological evaluations, which have shown the containers pass Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container systems.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
0.9% Sodium Chloride Injection, USP solution is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1,000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solution is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for injection, USP is chemically designated H2O. The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (freeflex® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
12 CELL SALTS COMPLEXCALCAREA FLUORICA CALCAREA PHOSPHORICA CALCAREA SULPHURICA FERRUM PHOSPHORICUM KALI MURIATICUM KALI PHOSPHORICUM KALI SULPHURICUM MAGNESIA PHOSPHORICA NATRUM MURIATICUM NATRUM PHOSPHORICUM NATRUM SULPHURICUM SILICEA
USES: FOR THE TEMPORARY RELIEF OF MINOR ACHES AND PAINS OF MUSCLES AND JOINTS ASSOCIATED WITH ARTHRITIS, SIMPLE BACKACHE, STRAINS, SPRAINS, MUSCLE SORENESS AND STIFFNESS.
INDICATIONS: For weight management and inflammation support. This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
3% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. The pH may have been adjusted with hydrochloric acid. It contains no antimicrobial agents. Composition, ionic concentration, osmolarity, and pH are shown in Table 1 . Table 1. *Normal physiological osmolarity range is approximately 280 to 310 mOsmol/L. Size (mL) Composition (g/L) Ionic Concentration (mEq/L) *Osmolarity (mOsmol/L) (calc) pH Sodium Chloride, USP (NaCl) Sodium Chloride 3% Sodium Chloride Injection, USP 500 30 513 513 1,027 5.0 (4.5 to 7.0) The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (free flex ® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
Uses* ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
Uses ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
HOMEOPATHIC INDICATIONS: For the temporary relief of symptoms related to illness and infections such as cold and flu.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to yeast syndrome including fatigue, malaise, weakness, headaches, GI disturbance, and anxiety.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to gingivitis, inflamed and bleeding gums and minor pain.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Virus Combination Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN HUMAN HERPESVIRUS 1 HUMAN HERPESVIRUS 1 HUMAN HERPESVIRUS 2 HUMAN HERPESVIRUS 2 HUMAN HERPESVIRUS 5 HUMAN HERPESVIRUS 5 HUMAN HERPESVIRUS 4 HUMAN HERPESVIRUS 4 HEPATITIS B VIRUS HEPATITIS B VIRUS NORWALK VIRUS NORWALK VIRUS WATER ALCOHOL
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to general viral infection (such as influenza, Epstein-Barr virus [EBV], cytomegalovirus [CMV], hepatitis, herpes, or adenovirus) including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Chlamydia Homochord Chlamydia Trachomatis CHLAMYDIA TRACHOMATIS CHLAMYDIA TRACHOMATIS WATER ALCOHOL
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to chlamydia infections. Male: burning sensation during urination, discharge from penis and testicular tenderness or pain. Female: vaginal discharge, burning sensation during urination, and painful sexual intercourse.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Uses For temporary relief of of discomforts associated with menopause: hot flashes night sweats chills headaches uterine cramps mood swings sensitivity irritability fatigue poor memory As per various homeopathic materia medicas. Claims based on traditional homeopathic practice, not accepted medical evidence. These uses have not been evaluated by the FDA, and product has not been clinically tested. Reference image: Menopause.jpg
HOMEOPATHIC INDICATIONS: For the temporary relief of swelling due to minor injury.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Uses For symptoms of restless legs, often worse at night: urge to move the legs heaviness muscle stiffness uneasiness in legs leg cramps burning sensation twitching, drawing, jerking legs as per various homeopathic materia medicas. Claims based on traditional homeopathic practice, not accepted medical evidence. These uses have not been evaluated by the FDA, and product has not been clinically tested. Reference image:Restless Leg.jpg
INDICATIONS: May temporarily relieve symptoms associated with decreased lymphatic drainage of the organs, such as fatigue, headache, lymphatic swelling, and bad effects from sedentary habits.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Pyrrole 1539 Pyrrole PYRROLE PYRROLE ALCOHOL WATER
INDICATIONS For the temporary relief of bloating, gas, anxiousness, insomnia, or occasional headache due to sensitivity to phenolic compounds found in foods or other products.*
INDICATIONS: For temporary relief of gastrointestinal dyspepsia (indigestion) with flatulence, bloating and intolerance of certain foods. Remedy #1 supports detoxification and cellular repair.
INDICATIONS: For temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue, and detoxification stress.
Gynetox Angelica Archangelica, Cimicifuga Racemosa, Zincum Gluconicum, Funiculus Umbilicalis Suis, Lymph Node (Suis), Oophorinum (Suis), Uterus (Suis), Glandula Suprarenalis Suis, Thyroidinum Suis, Boricum Acidum, Kreosotum, Mercurius Solubilis, Pulsatilla, Sepia, Calcarea Carbonica, Phosphorus, Sabina, Candida Albicans, Herpes Simplex 1 And 2 Nosode, Human Papilloma Virus Nosode ANGELICA ARCHANGELICA ROOT ANGELICA ARCHANGELICA ROOT BLACK COHOSH BLACK COHOSH ZINC GLUCONATE ZINC CATION SUS SCROFA UMBILICAL CORD SUS SCROFA UMBILICAL CORD SUS SCROFA LYMPH SUS SCROFA LYMPH SUS SCROFA OVARY SUS SCROFA OVARY SUS SCROFA UTERUS SUS SCROFA UTERUS SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND SUS SCROFA THYROID SUS SCROFA THYROID BORIC ACID BORIC ACID WOOD CREOSOTE WOOD CREOSOTE MERCURIUS SOLUBILIS MERCURIUS SOLUBILIS ANEMONE PULSATILLA ANEMONE PULSATILLA SEPIA OFFICINALIS JUICE SEPIA OFFICINALIS JUICE OYSTER SHELL CALCIUM CARBONATE, CRUDE OYSTER SHELL CALCIUM CARBONATE, CRUDE PHOSPHORUS PHOSPHORUS JUNIPERUS SABINA LEAFY TWIG JUNIPERUS SABINA LEAFY TWIG CANDIDA ALBICANS CANDIDA ALBICANS HUMAN HERPESVIRUS 1 HUMAN HERPESVIRUS 1 HUMAN HERPESVIRUS 2 HUMAN HERPESVIRUS 2 HUMAN PAPILLOMAVIRUS HUMAN PAPILLOMAVIRUS WATER ALCOHOL
INDICATIONS: May temporarily relieve symptoms associated with general inflammation, such as swelling, joint pain, allergies and irritation of eyes.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INDICATIONS: For support of symptoms of food and environmental sensitivities or intolerances due to slight errors in diet and exposure. May include mood changes, headaches, bloating, gas, and irritation in digestion.
INDICATIONS: For temporary relief of symptoms due to numbness, tingling, muscle cramps, and nerve pain.
Juglans Stannum Special Order Juglans Stannum Special Order WATER SODIUM CHLORIDE LACTOSE JUGLANS REGIA LEAF JUGLANS REGIA LEAF POTASSIUM PHOSPHATE, MONOBASIC PHOSPHATE ION TIN TIN
INDICATIONS: For temporary relief of symptoms related to chemical toxicity including fatigue, frequent colds, insomnia, headache, rash, constipation, and memory difficulties.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.